| Literature DB >> 25435906 |
Christopher Ko Williams1, Letizia Foroni2, Lucio Luzzatto2, Idris Saliu3, Arthur Levine4, Mel F Greaves5.
Abstract
Major differences exist in the nature of leukaemia and lymphoma in low-income African children compared to those in the high-income countries. These include the absence of the peak incidence of acute lymphoblastic leukaemia (ALL) in under-five-year olds that characterizes the disease in high-income countries. Conversely, chloroma association with acute myelogenous leukaemia (CA-AML/AMML) and Burkitt's lymphoma (BL) are rare in the high-income countries. This report describes clinical and laboratory as well as epidemiological features of childhood leukaemia and lymphoma reported betwen 1982 and 1984 in the city of Ibadan, Nigeria. The observed pattern of distribution of childhood haematological malignancies in the city is more consistent with the observations of Ludwik Gross's experiments on environmental influences, such as malnutrition and infections, animal leukaemogenesis, and mirroring the consequences of the primordial pressures that have shaped human genetics and pathophysiology.Entities:
Keywords: childhood leukaemia; chloroma; environmental factors; leukaemogenesis; lifestyle; lymphoblastic; socio-economic
Year: 2014 PMID: 25435906 PMCID: PMC4239129 DOI: 10.3332/ecancer.2014.478
Source DB: PubMed Journal: Ecancermedicalscience ISSN: 1754-6605
Patterns of rearrangement of immunoglobin (IgH), and T-cell receptor (TCR) beta- and gamma-genes, correlated with HTLV-I Western blot serology and DNA in leukaemia and lymphoma patients.
| GR Pattern | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALL | Eco RI | G/G | Eco RI | DG | RG | ND | ND | ND | – |
| 2 | ALL | Eco RI | G/G | Eco RI | GG | GG | ND | ND | ND | – |
| Hind III | G/G | |||||||||
| 3 | ALL | Hind III | G/G | Eco RI | GG | GG | ND | ND | ND | – |
| Eco RI | G/G | |||||||||
| 4 | ALL | Hind III | G/G | Eco RI | GG | GG | ND | ND | ND | – |
| Eco RI | G/G | |||||||||
| 5 | AML | Hind III | G/G | Eco RI | GG | GG | ND | ND | ND | – |
| Eco RI | G/G | |||||||||
| 6 | AML | ? | G/G | ? | GG | GG | ? | GG/GG | ND | – |
| 7 | ?CLL/?ALL | Hind III | G/G | Eco RI | GG | GG | ? | GG/GG | ND | – |
| 8 | B-CLL | Hind III | G/R | Eco RI | GG | GG | ND | ND | ND | – |
| 9 | B-CLL | Hind III | R1/R2 | Eco RI | GG | GG | ND | ND | ND | – |
| Eco RI | R1/R2 | |||||||||
| 10 | B-CLL | Hind III | D/R | Eco RI | GG | GG | ?? | GG/GG | NEG | – |
| Eco RI | D/R | |||||||||
| 11 | B-CLL | Hind III | G/G | Eco RI | GG | GG | ?? | GG/GG | NEG | – |
| 12 | B-CLL | Hind III Eco RI | G/G? | POS | – | |||||
| Eco RI | G/G? | |||||||||
| 13 | B-CLL | Hind III | R/G | Eco RI | GG | GG | ND | ND | POS | – |
| Eco RI | R1/R2 | |||||||||
| 14 | NHL-DL | Eco RI | G/G | Eco RI | GG | GG | ND | ND | ND | – |
| 15 | HD | ?? | GG | ?? | GG | GG | ND | – | ||
| 16 | NHL | ?? | G/G | GG | GG | ND | ND | – | ||
| ?? | ?/R | GG | GG | ND | ND | |||||
| 17 | BL | ?? | R1/R2 | ?? | GG | GG | ?? | ND | ND | – |
| 18 | AML | G/G | ?? | GG | GG | ?? | ND | ND | – | |
Restrict.: Restriction; GR pattn: Gene rearrangement pattern; ALL: Acute lymphoblastic leukaemia; AML: Acute myelogenous leukaemia; CLL: chronic lymphocytic leukaemia; B-CLL: B-cell chronic lymphocytic leukaemia; NHL-DL: Non Hodgkin’s lymphoma diffuse large-cell type; HD: Hodgkin’s disease (lymphoma); HTLV-I: Human T-cell leukaemia/lymphoma type 1; BL: Burkitt’s lymphoma; ND: Not done; G: Germ line pattern; R: rearranged pattern; IgH: immunoglobin heavy chain.
Pattern of acute lymphoblastic subtypes in Nigerians compared with those of the United States, UK, and Malaysia, including numbers of cases and frequency (%).
| Ibadan/Nigeria | USA (Caucasians) | United Kingdom | African-Americans | Malaysians | ||||
|---|---|---|---|---|---|---|---|---|
| Age–groups in years | <15 | ≥15 | <15 | ≥15 | <15 | ≥15 | <15 | <15 |
| c-ALL | 4 (22.2) | 8 (38.1) | 217 (74.4) | 37 (47.4) | 398 (73.2) | 23 (54.8) | 16 (55.2) | 7 (50.0) |
| Null ALL | 2 (11.1) | 1 (4.8) | 21 (7.2) | ? | 68 (12.5) | 11 (26.2) | 4 (13.8) | 3 (21.4) |
| T-ALL | 7 (38.9) | 11 (52.4) | 45 (15.5) | 20 (25.6) | 73 (13.5) | 5 (11.9) | 9 (31.0) | 4 (28.6) |
| B-ALL | 4 (22.2) | 1 (4.8) | 8 (2.7) | ? | 4 (0.7) | 1 (2.4) | 0 (0.0) | 0 (0.0) |
| Unclassifiable | 1 (5.6) | 0 (0.0) | 0 (0.0) | 21 (26.9) | 0 (0.0) | 2 (4.8) | 0 (0.0) | 0 (0.0) |
| Total | 18 (100) | 21 (100) | 291 (100) | 78 (100) | 542 (100) | 42 (100) | 29 (100) | 14 (100) |
Ibadan, Nigeria data based on this report.
USA (Caucasians) data based on [38]
African-American data based on [39]
United Kingdom (<15 years) data based on [37] and (≥15 years) data based on [61]
Malaysia data based on [62]
Comparative incidence of subtypes of acute lymphoblastic leukaemia in Nigerian, United Kingdom and US American children.
| Leukaemia subtypes | Nigerian | United Kingdom | USA Caucasian | African-American |
|---|---|---|---|---|
| ALL (all subtypes) | 0.8 | 2.61 | 2.46d | 1.26d |
| c-ALL | 0.18 | 1.91 | 1.83 | 0.70 |
| T-ALL | 0.31 | 0.35 | 0.38 | 0.40 |
| B-ALL | 0.18 | 0.02 | 0.06 | 0.0 |
: New cases per 100,000;
: [14];
: [35]; [36];
: derived from b and data in Table 2;
: derived from c and data in Table 2;
: derived from d and the data in Table 2.
Figure 1.Incidence of childhood leukaemia correlated with HAV seroprevalence in the first decade of life. US Cau. = US Caucasians. Data based on Smith et al [40] a. Acute lymphoblastic leukaemia in 2–4 year olds. b. HAV seroprevalence rates. In developing countries of Africa, Asia, Latin America, and pre-1960 Okinawa, Japan, where age-specific variations are not observed, cited infection rates represent cross-sectional values. In the developed countries of USA and United Kingdom as well as post-1960 Okinawa, Japan, the HAV values represent infection rates in the childbearing age of 25–30 years [65].
Estimated population sizes and incidence of haemopoietic malignancies among three socio-economic groups of inhabitants of Ibadan, Nigeria (1979–1978).
| Low (SES 4 + 5) | Medium (SES 3) | High (SES 1 + 2) | ||
|---|---|---|---|---|
| % of total population | 75 | 12.5 | 12.5 | |
| Estimated population size | 750–1500 | 125–250 | 125–250 | |
| Adults (53%) | 397.5–795 | 66.25–132.5 | 66.25–132.5 | |
| Children (47%) | 352.5–705.0 | 58.75–117.5 | 58.75–117.5 | |
| BL | <15 | [51] 1.81–3.62 | [1] 0.21–0.42 | [0] 0.0 |
| ALL | <15 | [8] 0.25–0.50 | [3] 0.56–1.13 | [4] 0.75–1.51 |
| AML | <15 | [13] 0.41–0.82 | [1] 0.18–0.37 | [1] 0.18–0.37 |
| ALL | ≥15 | [4] 0.11–0.22 | [0] 0.0 | [0] 0.33–0.67 |
| AML | ≥15 | [7] 0.20–0.39 | [1] 0.16–0.33 | [1] 0.16–0.33 |
| CML | ≥15 | [11] 0.17–0.33 | [2] 0.18–0.36 | [2] 0.18–0.36 |
| CLL | ≥15 | [14] 0.20–0.41 | [1] 0.09–0.17 | [1] 0.09–0.17 |
| HD | <15 | [6] 0.19–0.37 | [2] 0.42–0.85 | [0] 0.0 |
| HD | ≥15 | [16] 0.50–1.00 | [9] 1.70–3.40 | [0] 0.0 |
| NB/NHL | 0–80 | [25] 0.42–0.83 | [3] 0.30–0.60 | [2] 0.20–0.40 |
Leukaemia and lymphoma incidence (cases per 100,000 per year) is based on total number of cases(in bracket) accruing over 4.5 years (July, 1978 to December 1983) for leukaemia, and over 4 years(Jan. 1979 to December 1983) for lymphoma.
[63]
Projected from 1963 census figures at the estimated growth rate of between 2.5% and 5.0% [64].
World Bank [34].